aluates Reports

$ 0.0

Automative

Global Pet Anthelmintic Drugs Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-18P13582

Global Pet Anthelmintic Drugs Market Research Report 2023

BUY CHAPTERS

Global Pet Anthelmintic Drugs Market Research Report 2025

Code: QYRE-Auto-18P13582

Report

June 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Ceva Sante Animale

Chanelle Group

Dechra

Durvet

First Priority

Jeffers

Manna Pro Products

Merck Animal Health

Ourofino

TTK Healthcare

Vetoquinol

Virbac

Zoetis Inc

Boehringer Ingelheim

Elanco

Pet Anthelmintic Drugs Market Size

According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021.

Pet Anthelmintic Drugs Market

The global market for Pet Anthelmintic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 45%.

This report aims to provide a comprehensive presentation of the global market for Pet Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Anthelmintic Drugs.

The Pet Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet Anthelmintic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pet Anthelmintic Drugs Market Report

Report Metric	Details
Report Name	Pet Anthelmintic Drugs Market
Accounted market size in 2021	$ 38.3 billion
Base Year	2021
Segment by Type	External Internal Composite Injection
Segment by Application	Dog Cat Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Elanco, Boehringer Ingelheim, Ceva Sante Animale, Chanelle Group, Dechra, Durvet, First Priority, Jeffers, Manna Pro Products, Merck Animal Health, Ourofino, TTK Healthcare, Vetoquinol, Virbac, Zoetis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Anthelmintic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Pet Anthelmintic Drugs Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet Anthelmintic Drugs Market report?

Ans: The main players in the Pet Anthelmintic Drugs Market are Elanco, Boehringer Ingelheim, Ceva Sante Animale, Chanelle Group, Dechra, Durvet, First Priority, Jeffers, Manna Pro Products, Merck Animal Health, Ourofino, TTK Healthcare, Vetoquinol, Virbac, Zoetis

What are the Application segmentation covered in the Pet Anthelmintic Drugs Market report?

Ans: The Applications covered in the Pet Anthelmintic Drugs Market report are Dog, Cat, Others

What are the Type segmentation covered in the Pet Anthelmintic Drugs Market report?

Ans: The Types covered in the Pet Anthelmintic Drugs Market report are External, Internal, Composite, Injection

Recommended Reports

Animal Healthcare Markets

Pet Medications

Pet Industry Products

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 External

1.2.3 Internal

1.2.4 Composite

1.2.5 Injection

1.3 Market by Application

1.3.1 Global Pet Anthelmintic Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Dog

1.3.3 Cat

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pet Anthelmintic Drugs Market Perspective (2020-2031)

2.2 Global Pet Anthelmintic Drugs Growth Trends by Region

2.2.1 Global Pet Anthelmintic Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pet Anthelmintic Drugs Historic Market Size by Region (2020-2025)

2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Region (2026-2031)

2.3 Pet Anthelmintic Drugs Market Dynamics

2.3.1 Pet Anthelmintic Drugs Industry Trends

2.3.2 Pet Anthelmintic Drugs Market Drivers

2.3.3 Pet Anthelmintic Drugs Market Challenges

2.3.4 Pet Anthelmintic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pet Anthelmintic Drugs Players by Revenue

3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2020-2025)

3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pet Anthelmintic Drugs Revenue

3.4 Global Pet Anthelmintic Drugs Market Concentration Ratio

3.4.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2024

3.5 Global Key Players of Pet Anthelmintic Drugs Head office and Area Served

3.6 Global Key Players of Pet Anthelmintic Drugs, Product and Application

3.7 Global Key Players of Pet Anthelmintic Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pet Anthelmintic Drugs Breakdown Data by Type

4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2020-2025)

4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2026-2031)

5 Pet Anthelmintic Drugs Breakdown Data by Application

5.1 Global Pet Anthelmintic Drugs Historic Market Size by Application (2020-2025)

5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pet Anthelmintic Drugs Market Size (2020-2031)

6.2 North America Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pet Anthelmintic Drugs Market Size by Country (2020-2025)

6.4 North America Pet Anthelmintic Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pet Anthelmintic Drugs Market Size (2020-2031)

7.2 Europe Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pet Anthelmintic Drugs Market Size by Country (2020-2025)

7.4 Europe Pet Anthelmintic Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pet Anthelmintic Drugs Market Size (2020-2031)

8.2 Asia-Pacific Pet Anthelmintic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pet Anthelmintic Drugs Market Size (2020-2031)

9.2 Latin America Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pet Anthelmintic Drugs Market Size by Country (2020-2025)

9.4 Latin America Pet Anthelmintic Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pet Anthelmintic Drugs Market Size (2020-2031)

10.2 Middle East & Africa Pet Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Elanco

11.1.1 Elanco Company Details

11.1.2 Elanco Business Overview

11.1.3 Elanco Pet Anthelmintic Drugs Introduction

11.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.1.5 Elanco Recent Development

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Details

11.2.2 Boehringer Ingelheim Business Overview

11.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction

11.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.2.5 Boehringer Ingelheim Recent Development

11.3 Ceva Sante Animale

11.3.1 Ceva Sante Animale Company Details

11.3.2 Ceva Sante Animale Business Overview

11.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction

11.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.3.5 Ceva Sante Animale Recent Development

11.4 Chanelle Group

11.4.1 Chanelle Group Company Details

11.4.2 Chanelle Group Business Overview

11.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction

11.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.4.5 Chanelle Group Recent Development

11.5 Dechra

11.5.1 Dechra Company Details

11.5.2 Dechra Business Overview

11.5.3 Dechra Pet Anthelmintic Drugs Introduction

11.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.5.5 Dechra Recent Development

11.6 Durvet

11.6.1 Durvet Company Details

11.6.2 Durvet Business Overview

11.6.3 Durvet Pet Anthelmintic Drugs Introduction

11.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.6.5 Durvet Recent Development

11.7 First Priority

11.7.1 First Priority Company Details

11.7.2 First Priority Business Overview

11.7.3 First Priority Pet Anthelmintic Drugs Introduction

11.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.7.5 First Priority Recent Development

11.8 Jeffers

11.8.1 Jeffers Company Details

11.8.2 Jeffers Business Overview

11.8.3 Jeffers Pet Anthelmintic Drugs Introduction

11.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.8.5 Jeffers Recent Development

11.9 Manna Pro Products

11.9.1 Manna Pro Products Company Details

11.9.2 Manna Pro Products Business Overview

11.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction

11.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.9.5 Manna Pro Products Recent Development

11.10 Merck Animal Health

11.10.1 Merck Animal Health Company Details

11.10.2 Merck Animal Health Business Overview

11.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction

11.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.10.5 Merck Animal Health Recent Development

11.11 Ourofino

11.11.1 Ourofino Company Details

11.11.2 Ourofino Business Overview

11.11.3 Ourofino Pet Anthelmintic Drugs Introduction

11.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.11.5 Ourofino Recent Development

11.12 TTK Healthcare

11.12.1 TTK Healthcare Company Details

11.12.2 TTK Healthcare Business Overview

11.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction

11.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.12.5 TTK Healthcare Recent Development

11.13 Vetoquinol

11.13.1 Vetoquinol Company Details

11.13.2 Vetoquinol Business Overview

11.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction

11.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.13.5 Vetoquinol Recent Development

11.14 Virbac

11.14.1 Virbac Company Details

11.14.2 Virbac Business Overview

11.14.3 Virbac Pet Anthelmintic Drugs Introduction

11.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.14.5 Virbac Recent Development

11.15 Zoetis

11.15.1 Zoetis Company Details

11.15.2 Zoetis Business Overview

11.15.3 Zoetis Pet Anthelmintic Drugs Introduction

11.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2020-2025)

11.15.5 Zoetis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Ceva Sante Animale

Chanelle Group

Dechra

Durvet

First Priority

Jeffers

Manna Pro Products

Merck Animal Health

Ourofino

TTK Healthcare

Vetoquinol

Virbac

Zoetis Inc

Boehringer Ingelheim

Elanco

List of Tables

Table 1. Global Pet Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of External

Table 3. Key Players of Internal

Table 4. Key Players of Composite

Table 5. Key Players of Injection

Table 6. Global Pet Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pet Anthelmintic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Pet Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Pet Anthelmintic Drugs Market Share by Region (2020-2025)

Table 10. Global Pet Anthelmintic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Pet Anthelmintic Drugs Market Share by Region (2026-2031)

Table 12. Pet Anthelmintic Drugs Market Trends

Table 13. Pet Anthelmintic Drugs Market Drivers

Table 14. Pet Anthelmintic Drugs Market Challenges

Table 15. Pet Anthelmintic Drugs Market Restraints

Table 16. Global Pet Anthelmintic Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Pet Anthelmintic Drugs Market Share by Players (2020-2025)

Table 18. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2024)

Table 19. Ranking of Global Top Pet Anthelmintic Drugs Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Pet Anthelmintic Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Pet Anthelmintic Drugs, Headquarters and Area Served

Table 22. Global Key Players of Pet Anthelmintic Drugs, Product and Application

Table 23. Global Key Players of Pet Anthelmintic Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Pet Anthelmintic Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2020-2025)

Table 27. Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2026-2031)

Table 29. Global Pet Anthelmintic Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2020-2025)

Table 31. Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Pet Anthelmintic Drugs Revenue Market Share by Application (2026-2031)

Table 33. North America Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Pet Anthelmintic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Pet Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. Elanco Company Details

Table 49. Elanco Business Overview

Table 50. Elanco Pet Anthelmintic Drugs Product

Table 51. Elanco Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 52. Elanco Recent Development

Table 53. Boehringer Ingelheim Company Details

Table 54. Boehringer Ingelheim Business Overview

Table 55. Boehringer Ingelheim Pet Anthelmintic Drugs Product

Table 56. Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 57. Boehringer Ingelheim Recent Development

Table 58. Ceva Sante Animale Company Details

Table 59. Ceva Sante Animale Business Overview

Table 60. Ceva Sante Animale Pet Anthelmintic Drugs Product

Table 61. Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 62. Ceva Sante Animale Recent Development

Table 63. Chanelle Group Company Details

Table 64. Chanelle Group Business Overview

Table 65. Chanelle Group Pet Anthelmintic Drugs Product

Table 66. Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 67. Chanelle Group Recent Development

Table 68. Dechra Company Details

Table 69. Dechra Business Overview

Table 70. Dechra Pet Anthelmintic Drugs Product

Table 71. Dechra Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 72. Dechra Recent Development

Table 73. Durvet Company Details

Table 74. Durvet Business Overview

Table 75. Durvet Pet Anthelmintic Drugs Product

Table 76. Durvet Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 77. Durvet Recent Development

Table 78. First Priority Company Details

Table 79. First Priority Business Overview

Table 80. First Priority Pet Anthelmintic Drugs Product

Table 81. First Priority Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 82. First Priority Recent Development

Table 83. Jeffers Company Details

Table 84. Jeffers Business Overview

Table 85. Jeffers Pet Anthelmintic Drugs Product

Table 86. Jeffers Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 87. Jeffers Recent Development

Table 88. Manna Pro Products Company Details

Table 89. Manna Pro Products Business Overview

Table 90. Manna Pro Products Pet Anthelmintic Drugs Product

Table 91. Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 92. Manna Pro Products Recent Development

Table 93. Merck Animal Health Company Details

Table 94. Merck Animal Health Business Overview

Table 95. Merck Animal Health Pet Anthelmintic Drugs Product

Table 96. Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 97. Merck Animal Health Recent Development

Table 98. Ourofino Company Details

Table 99. Ourofino Business Overview

Table 100. Ourofino Pet Anthelmintic Drugs Product

Table 101. Ourofino Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 102. Ourofino Recent Development

Table 103. TTK Healthcare Company Details

Table 104. TTK Healthcare Business Overview

Table 105. TTK Healthcare Pet Anthelmintic Drugs Product

Table 106. TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 107. TTK Healthcare Recent Development

Table 108. Vetoquinol Company Details

Table 109. Vetoquinol Business Overview

Table 110. Vetoquinol Pet Anthelmintic Drugs Product

Table 111. Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 112. Vetoquinol Recent Development

Table 113. Virbac Company Details

Table 114. Virbac Business Overview

Table 115. Virbac Pet Anthelmintic Drugs Product

Table 116. Virbac Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 117. Virbac Recent Development

Table 118. Zoetis Company Details

Table 119. Zoetis Business Overview

Table 120. Zoetis Pet Anthelmintic Drugs Product

Table 121. Zoetis Revenue in Pet Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 122. Zoetis Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Pet Anthelmintic Drugs Picture

Figure 2. Global Pet Anthelmintic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pet Anthelmintic Drugs Market Share by Type: 2024 VS 2031

Figure 4. External Features

Figure 5. Internal Features

Figure 6. Composite Features

Figure 7. Injection Features

Figure 8. Global Pet Anthelmintic Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Pet Anthelmintic Drugs Market Share by Application: 2024 VS 2031

Figure 10. Dog Case Studies

Figure 11. Cat Case Studies

Figure 12. Others Case Studies

Figure 13. Pet Anthelmintic Drugs Report Years Considered

Figure 14. Global Pet Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Pet Anthelmintic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Pet Anthelmintic Drugs Market Share by Region: 2024 VS 2031

Figure 17. Global Pet Anthelmintic Drugs Market Share by Players in 2024

Figure 18. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2024

Figure 20. North America Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Pet Anthelmintic Drugs Market Share by Country (2020-2031)

Figure 22. United States Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Pet Anthelmintic Drugs Market Share by Country (2020-2031)

Figure 26. Germany Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Pet Anthelmintic Drugs Market Share by Region (2020-2031)

Figure 34. China Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Pet Anthelmintic Drugs Market Share by Country (2020-2031)

Figure 42. Mexico Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Pet Anthelmintic Drugs Market Share by Country (2020-2031)

Figure 46. Turkey Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Pet Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Elanco Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 50. Boehringer Ingelheim Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 51. Ceva Sante Animale Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 52. Chanelle Group Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 53. Dechra Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 54. Durvet Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 55. First Priority Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 56. Jeffers Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 57. Manna Pro Products Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 58. Merck Animal Health Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 59. Ourofino Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 60. TTK Healthcare Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 61. Vetoquinol Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 62. Virbac Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 63. Zoetis Revenue Growth Rate in Pet Anthelmintic Drugs Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Animal Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Companion Animal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dog Parasiticides Market Research Report 2025

Veterinary Anti Infectives Market

Global Companion Animal Speciality Drugs Market Research Report 2024

Feed Additives for Ruminants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet OTC Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Pain Management Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cat Parasiticides Market Research Report 2025

Global Insects as Animal Feed Market Insights Forecast to 2030

Companion Animal Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibiotics for Dogs and Cats Market Research Report 2025

Global Dog And Cat Joint Health Supplement Market Research Report 2025

Pet Smart Cameras Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Ophthalmic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Import and Export Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal Antibiotic and Antimicrobial Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Compound Feed for Animal Nutrition Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Biopharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions